Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
OGI~OrganiGram Corporate Update https://organigram.ca/press-releases/organigram-provides-corporate-update-achieves-2-market-share-over-the-last-two
Organigram Provides Corporate Update Achieves #2 Market Share Over the Last Two Months October 18th, 2023
Toronto, Ontario – October 18, 2023 - Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to provide a corporate update.
Hopefully they were not just giving it away to become that spot. We need better margins and cut overhead.
Very concerned and very surprised about this.
Thanks Hunchbackgeek
"Organigram Provides Corporate Update Achieves #2 Market Share Over the Last Two Months October 18th, 2023" https://organigram.ca/press-releases/organigram-provides-corporate-update-achieves-2-market-share-over-the-last-two
Toronto, Ontario – October 18, 2023 - Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to provide a corporate update.
LINK FOR FULL NEWS RELEASE: https://organigram.ca/press-releases/organigram-provides-corporate-update-achieves-2-market-share-over-the-last-two
Better be careful of another reverse split in the future.
So reading up, they might have several weeks to several months before they get approval (or not). Makes me wonder if they plan to use this once the usa comes online, which we should hear about that within the next month or so
Now that is going to hurt unless it's used right.
Organigram Holdings Inc. Files Final Base Shelf Prospectus ~ October 12th, 2023
TORONTO – (BUSINESS WIRE) – October 11, 2023 – Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licenced producer of cannabis, announced today that it has obtained a receipt for a final short form base shelf prospectus (the “Base Shelf Prospectus”) filed with the securities commissions in each of the provinces and territories of Canada. A corresponding shelf registration statement on Form F-10 (the “Registration Statement”) has been filed with the United States Securities and Exchange Commission (SEC File No. 333-274686) but is not yet effective.
The Base Shelf Prospectus enables Organigram to qualify the distribution of up to C$500,000,000 of common shares, debt securities, subscription receipts, warrants, and units during the 25-month period that the Base Shelf Prospectus remains effective. The specific terms of any future offering of securities will ?be established in a prospectus supplement filed with the applicable Canadian and US regulatory authorities. The Base Shelf Prospectus will provide flexibility for financing options to pursue the Company’s objectives.
A copy of the Base Shelf Prospectus can be found on SEDAR+ at www.sedarplus.ca and a copy of the Registration Statement can be found on EDGAR at www.sec.gov.
No offer to buy any securities of the Company can be accepted until the Registration Statement has become effective.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiaries include: Organigram Inc. a licensed producer of cannabis, cannabis-derived products and cannabis infused edibles in Canada.
Organigram is focused on producing high-quality cannabis for patients and adult recreational consumers, as well as developing international business partnerships to extend the Company's global footprint. Organigram has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour, Laurentian, Tremblant Cannabis and Trailblazer. Organigram operates facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).
Forward-Looking Information
This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include factors and risks as disclosed in the Company’s most recent annual information form, management’s discussion and analysis and other Company documents filed from time to time on SEDAR+ (see www.sedarplus.ca) and filed or furnished to the Securities and Exchange Commission on EDGAR (see www.sec.gov). In addition, there can be no assurance that Organigram will obtain a receipt qualifying a final short form base shelf prospectus, that any prospectus supplements will be filed, that any financings will be completed under the short form base shelf prospectus, and that the objectives sought from any financings will be fulfilled. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
For Investor Relations enquiries:
Max Schwartz
Director of Investor Relations
investors@organigram.ca
Organigram
For Media enquiries:
Megan McCrae
Senior Vice President – Marketing and Communications
megan.mccrae@organigram.ca
Organigram
This is getting very painful
Organigram Holdings Inc. Files Preliminary Base Shelf Prospectus
Potential dilution.
https://ih.advfn.com/stock-market/NASDAQ/organigram-OGI/stock-news/92120401/organigram-holdings-inc-files-preliminary-base-sh
Pretty pissed whats going on here. Not sure if the company really screwed things up this bad or if it's just the market. Anyone look to see when tbe next CC/Quarter comes out?
Truly a transition year. Do you have a spare 59 Bel Air?
Ogi is like my delayed baby, it's taking a little longer to walk, but when it learns to run, it's going to run fast.
Not a chart reader but when I look at the Bollinger Bands on my trading platform, this has a pretty good chance to start the next leg up tomorrow!
Yeah, finally many of my cannabis stocks are back in the green! Hopefully this starts to runs like acb is doing right now.
WOW, that was nice. Could we do it again tomorrow, please?
Up $.28 today.
Wonder what caused that?
I didn't see where anyone posted the results and outcome about jolt... so hopefully a good quarter comes once again! https://www.pharmainbrief.com/2023/09/federal-court-finds-that-health-canada-breached-procedural-fairness-by-relying-on-an-undisclosed-internal-guidance-document/
Hopefully all the cannabis stocks have another green day! Enjoy the ride!
Organigram Launches First Range of THCV Products Derived from Moncton- Grown Whole Flower
First lineup of THCV products enabled by Organigram’s strategic investment in Phylos Bioscience ~ August 28th, 2023
THCV now available in Canada!
https://investors.organigram.ca/press-releases/organigram-launches-first-range-of-thcv-products-derived-from-moncton-grown-whole
Toronto, Ontario – August 28, 2023 - Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to launch its first range of whole-flower derived THCV products through the Company’s popular SHRED and newly re-launched Trailblazer brands.
Reaffirming its commitment to forward-looking innovation, Organigram strives to maintain a competitive advantage in the cannabis industry, most recently through its strategic investment in Phylos Bioscience, a US-based leader in cannabis genetics. Through this investment, Organigram cultivates and extracts THCV in-house in its state-of-the-art Moncton facility and is currently believed to be the only Canadian licensed producer (LP) to do so.
THCV is a novel and rare cannabinoid often referenced for its appetite suppressing effects . THCV is a compelling offering for consumers because, like CBD, it is reported to be non-psychoactive2, and acts as an antagonist for some of the qualities associated with THC. For example, THCV is reported to mitigate the appetite stimulation1 associated with THC, earning it the nickname “Diet Weed”, and is also gaining popularity for its reported ‘super sativa’ effects of wellness, energy and focus.2
Organigram has exclusive Canadian rights to all THCV cultivars from Phylos, including Get S**t Done (1:3 THC:THCV) and Joyride (1:1 THC:THCV), two popular cultivars with THCV concentrations that are significantly higher than anything else currently available in the market. Phylos has developed, and continues to develop, proprietary high-THCV genetics in various THC:THCV ratios where each ratio creates a differentiated user experience and can be delivered in a wide range of product formats.
“At Organigram, our commitment to scientific excellence, rigorous research, and consumer-driven innovation sets us apart in the industry,” says Borna Zlamalik, Senior Vice President of Innovation and R&D at Organigram. “We are currently the only licensed Canadian cannabis company to be cultivating and extracting from THCV flower, meaning that our products are made from the entire cannabis flower, including cannabinoids, terpenes, flavonoids, and other compounds. They are extracted directly from the cannabis plant using methods like CO2 and solventless cold water extraction. Our products are naturally (and not synthetically) derived, not created through chemical processes in a laboratory setting. This is a testament to our extraordinary R&D, exceptional talent, and the incredible capabilities we have in-house,” he added.
Organigram’s first THCV range of products include:
SHRED’ems Guava Lime Go–Time: This exotic new flavour profile, bursting with guava and lime flavours provides a unique cannabinoid experience with an initial 1:1 THC:THCV (10mg THC + 10mg THCV) ratio per pack. An entry point for those looking to experience this new minor cannabinoid.
Trailblazer Zen Garden Grapefruit: A THCV-forward, grapefruit flavoured sugar-free gummy, that offers more THCV than any other gummy in the market with an initial 1:2 THC:THCV (10mg THC + 20mg THCV) ratio per pack.
“In this era of heightened awareness, we recognize that consumers expect more from cannabis producers, and our commitment as an industry-leading Licensed Producer is to exceed those expectations. By harnessing the power of THCV through our strategic investment, we are reshaping the cannabis experience for consumers,” says Megan McCrae, Senior Vice President of Marketing and Communications at Organigram.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiaries include: Organigram Inc. and Laurentian Organic Inc., licensed producers of cannabis and cannabis-derived products in Canada, and The Edibles and Infusions Corporation, a licensed manufacturer of cannabis-infused edibles in Canada. Organigram is focused on producing high-quality, cannabis for patients and adult recreational consumers, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour, Laurentian, Tremblant Cannabis and Trailblazer. Organigram operates facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).
Forward-Looking Information
This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include changes to market conditions, consumer preferences and regulatory climate including change in regulation of minor cannabinoids such as THC-V, and factors and risks as disclosed in the Company’s most recent annual information form, management’s discussion and analysis and other Company documents filed from time to time on SEDAR (see www.sedar.com) and filed or furnished to the Securities and Exchange Commission on EDGAR (see www.sec.gov). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
For Investor Relations enquiries:
Max Schwartz
Director of Investor Relations
investors@organigram.ca
Organigram
For Media enquiries:
Megan McCrae
Senior Vice President of Marketing and Communications
megan.mccrae@organigram.ca
Organigram
Footnotes:
Jadoon, Khalid A et al. “Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study.” Diabetes care vol. 39,10 (2016): 1777-86. doi:10.2337/dc16-0650 https://pubmed.ncbi.nlm.nih.gov/27573936/
Cascio, Maria Grazia et al. “The phytocannabinoid, ??-tetrahydrocannabivarin, can act through 5-HT1A receptors to produce antipsychotic effects.” British journal of pharmacology vol. 172,5 (2015): 1305-18. doi:10.1111/bph.13000 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337703/
SOURCE: https://investors.organigram.ca/press-releases/organigram-launches-first-range-of-thcv-products-derived-from-moncton-grown-whole
.
Pot stocks rally
Cannabis stocks were higher on Wednesday after the Department of Health and Human Services reportedly recommended the Drug Enforcement Administration (DEA) reclassify marijuana as a lower-risk drug.
https://www.foxbusiness.com/markets/pot-stocks-rally-after-health-officials-ask-dea-reclassify-marijuana-lower-risk-drug
OGI~Organigram Launches First Range of THCV Products Derived from Moncton- Grown Whole Flower
First lineup of THCV products enabled by Organigram’s strategic investment in Phylos Bioscience
https://investors.organigram.ca/press-releases/organigram-launches-first-range-of-thcv-products-derived-from-moncton-grown-whole
Toronto, Ontario – August 28, 2023 - Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to launch its first range of whole-flower derived THCV products through the Company’s popular SHRED and newly re-launched Trailblazer brands.
Reaffirming its commitment to forward-looking innovation, Organigram strives to maintain a competitive advantage in the cannabis industry, most recently through its strategic investment in Phylos Bioscience, a US-based leader in cannabis genetics. Through this investment, Organigram cultivates and extracts THCV in-house in its state-of-the-art Moncton facility and is currently believed to be the only Canadian licensed producer (LP) to do so.
THCV is a novel and rare cannabinoid often referenced for its appetite suppressing effects . THCV is a compelling offering for consumers because, like CBD, it is reported to be non-psychoactive2, and acts as an antagonist for some of the qualities associated with THC. For example, THCV is reported to mitigate the appetite stimulation1 associated with THC, earning it the nickname “Diet Weed”, and is also gaining popularity for its reported ‘super sativa’ effects of wellness, energy and focus.2
Organigram has exclusive Canadian rights to all THCV cultivars from Phylos, including Get S**t Done (1:3 THC:THCV) and Joyride (1:1 THC:THCV), two popular cultivars with THCV concentrations that are significantly higher than anything else currently available in the market. Phylos has developed, and continues to develop, proprietary high-THCV genetics in various THC:THCV ratios where each ratio creates a differentiated user experience and can be delivered in a wide range of product formats.
“At Organigram, our commitment to scientific excellence, rigorous research, and consumer-driven innovation sets us apart in the industry,” says Borna Zlamalik, Senior Vice President of Innovation and R&D at Organigram. “We are currently the only licensed Canadian cannabis company to be cultivating and extracting from THCV flower, meaning that our products are made from the entire cannabis flower, including cannabinoids, terpenes, flavonoids, and other compounds. They are extracted directly from the cannabis plant using methods like CO2 and solventless cold water extraction. Our products are naturally (and not synthetically) derived, not created through chemical processes in a laboratory setting. This is a testament to our extraordinary R&D, exceptional talent, and the incredible capabilities we have in-house,” he added.
Organigram’s first THCV range of products include:
SHRED’ems Guava Lime Go–Time: This exotic new flavour profile, bursting with guava and lime flavours provides a unique cannabinoid experience with an initial 1:1 THC:THCV (10mg THC + 10mg THCV) ratio per pack. An entry point for those looking to experience this new minor cannabinoid.
Trailblazer Zen Garden Grapefruit: A THCV-forward, grapefruit flavoured sugar-free gummy, that offers more THCV than any other gummy in the market with an initial 1:2 THC:THCV (10mg THC + 20mg THCV) ratio per pack.
“In this era of heightened awareness, we recognize that consumers expect more from cannabis producers, and our commitment as an industry-leading Licensed Producer is to exceed those expectations. By harnessing the power of THCV through our strategic investment, we are reshaping the cannabis experience for consumers,” says Megan McCrae, Senior Vice President of Marketing and Communications at Organigram.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiaries include: Organigram Inc. and Laurentian Organic Inc., licensed producers of cannabis and cannabis-derived products in Canada, and The Edibles and Infusions Corporation, a licensed manufacturer of cannabis-infused edibles in Canada. Organigram is focused on producing high-quality, cannabis for patients and adult recreational consumers, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour, Laurentian, Tremblant Cannabis and Trailblazer. Organigram operates facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).
Forward-Looking Information
This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include changes to market conditions, consumer preferences and regulatory climate including change in regulation of minor cannabinoids such as THC-V, and factors and risks as disclosed in the Company’s most recent annual information form, management’s discussion and analysis and other Company documents filed from time to time on SEDAR (see www.sedar.com) and filed or furnished to the Securities and Exchange Commission on EDGAR (see www.sec.gov). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
For Investor Relations enquiries:
Max Schwartz
Director of Investor Relations
investors@organigram.ca
Organigram
For Media enquiries:
Megan McCrae
Senior Vice President of Marketing and Communications
megan.mccrae@organigram.ca
Organigram
Footnotes:
Jadoon, Khalid A et al. “Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study.” Diabetes care vol. 39,10 (2016): 1777-86. doi:10.2337/dc16-0650 https://pubmed.ncbi.nlm.nih.gov/27573936/
Cascio, Maria Grazia et al. “The phytocannabinoid, ??-tetrahydrocannabivarin, can act through 5-HT1A receptors to produce antipsychotic effects.” British journal of pharmacology vol. 172,5 (2015): 1305-18. doi:10.1111/bph.13000 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337703/
SOURCE: https://investors.organigram.ca/press-releases/organigram-launches-first-range-of-thcv-products-derived-from-moncton-grown-whole
.
Right on Puff Puff Pass
"Organigram Relaunches one of Canada’s First Cannabis Brands, Trailblazer"
Trailblazer returns to the Canadian marketplace with a new range of products ~ August 21st, 2023 OGI
https://investors.organigram.ca/press-releases/organigram-relaunches-one-of-canadas-first-cannabis-brands-trailblazer
That's alot of kilos! "High Margin" wonder how much is really locked in. All goo $ in anycase
OGI~United Kingdom Agreement to Supply Medical Cannabis https://investors.organigram.ca/press-releases/organigram-to-enter-the-united-kingdom-with-agreement-to-supply-medical-cannabis-to
FULL TITLE:
August 15th, 2023
"Organigram to Enter the United Kingdom with Agreement to Supply Medical Cannabis to 4C LABS"
Organigram to Enter the United Kingdom with Agreement to Supply Medical Cannabis to 4C LABS Organigram and 4C Labs ~ August 15th, 2023
Organigram to supply 4C LABS with high-quality Medical Cannabis for distribution to UK Medical Cannabis patients
Organigram chosen by 4C LABS to be the preferred supplier of Medical Cannabis flower to deliver innovative new products to the UK market
First year of the agreement expected to reach approximately 600 kilograms of high margin Medical Cannabis flower, with increasing targets in the following 2 years
Organigram to grant limited strain exclusivity for cultivars distributed by 4C LABS
Organigram now has international supply agreements in place with Israel, Australia, Germany, and the United Kingdom, reflecting Organigram’s strategy to expand beyond Canada into international markets including Europe and the UK
Toronto August 15, 2023 -- Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce today that it has expanded its global footprint by entering into a supply agreement (“the Agreement”) to provide dried Medical Cannabis flower to 4C LABS, a rapidly scaling healthcare, technology, and pharmaceutical company focused on virtual prescribing, pharmaceutical distribution, and clinical development of cannabis-based products for human health in the United Kingdom.
Under the terms of the Agreement, the Company expects to supply approximately 600 kilograms of high-quality, indoor-grown dried flower product to 4C LABS within the first year of the Agreement, and grant 4C LABS strain exclusivity within the geographical boundaries of the United Kingdom & Channel Islands for as long as minimum purchase commitments are satisfied.
“Medical Cannabis has been legal in the UK since 2018. However, due to significant energy cost premiums compared to Canada, access to consistent, high-quality products in this market is limited, making importing Medical Cannabis an attractive option for this growing market” says Beena Goldenberg, Chief Executive Officer of Organigram. “We are excited to partner with 4C LABS to increase access to Medical Cannabis for UK Medical Cannabis patients.”
“4C LABS is focused on delivering a value proposition to UK patients, 4C LABS provides top quality products, industry leading pricing, best in class customer service and a robust supply chain. says Greg Dobbin, Chief Executive Officer of 4C LABS. “We are excited to bring Organigram products to the UK & Channel Islands.”
Activities under the Agreement are subject to compliance with all applicable laws, including receipt from time to time of all requisite approvals from Health Canada, the UK Medicines and Healthcare Products Regulatory Agency, and any other applicable regulatory authorities.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiaries include: Organigram Inc. and Laurentian Organic Inc., licensed producers of cannabis and cannabis-derived products in Canada, and The Edibles and Infusions Corporation, a licensed manufacturer of cannabis-infused edibles in Canada.
Organigram is focused on producing high-quality, cannabis for patients and adult recreational consumers, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour, Laurentian, Tremblant Cannabis and Trailblazer. Organigram operates facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).
About 4C Labs
4C LABS is a healthcare, technology and pharmaceutical company focused on virtual prescribing, pharmaceutical distribution and clinical development in cannabis based medicinal products (CBMP’s) for human health. 4C LABS is committed to advancing scientific research, as well as enabling the regulation, distribution and prescribing of CBPM's in the UK and Channel Islands. Its work with leading scientists, specialist physicians and pharmacists is underpinned with disruptive technologies that are driving an approach to treatment that prioritizes patients and evidence over stigma. 4C LABS works closely with Drug Science, the Cannabis Industry Council (CIC), The Medicines and Healthcare Products Regulatory Agency (MHRA) and the Care Quality Commission (CQC) to catalyze safe, regulated change in the medical landscape. 4C LABS is fully licensed in the UK with MS WDA, Schedule 1 Narcotics and Production licenses.
Forward-Looking Information
This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include changes to market conditions, consumer preferences and ability to meet minimum purchase commitments and targets and regulatory climate, and factors and risks as disclosed in the Company’s most recent annual information form, management’s discussion and analysis and other Company documents filed from time to time on SEDAR (see www.sedar.com) and filed or furnished to the Securities and Exchange Commission on EDGAR (see www.sec.gov). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all.
This news release contains information concerning the cannabis industry and the markets in which the Company operates, including market position and market share, which is based on information from independent third-party sources. Although we believe these sources to be generally reliable, market and industry data is inherently imprecise, subject to interpretation and cannot be verified with complete certainty due to limits on the availability and reliability of raw data, the voluntary nature of the data gathering process, and other limitations and uncertainties inherent in any statistical survey or data collection process. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
For media enquiries:
Megan McCrae
Senior Vice-President of Marketing and Communications
megan.mccrae@organigram.ca
For investor enquiries:
Max Schwartz
Director of Investor Relations
investors@organigram.ca
https://investors.organigram.ca/press-releases/organigram-to-enter-the-united-kingdom-with-agreement-to-supply-medical-cannabis-to
Thanks HunchBackGeek
Yes, I hope people checkout the link, OrganiGram did a super job with the presentation. https://investors.organigram.ca/press-releases/organigram-launches-new-tube-style-pre-rolls-shred-dartz-and-holy-smokes
OGI
HBG, good to add new products or variations on existing.
Maybe that equates to more shelf space?
But, what it really comes down to is the financials, especially the Income Statement.
As that gets better, so will the stock price. Simple, right? SMH
In the meantime, I'll hold my core position and try to reduce my basis.
Good luck, I hope you do well.
this one should be ready----surprised it isnt bt out by now by someone wanting a foothold in the sector on the cheap---i have mine!-----tmonkey
Thanks HunchBackGeek
Organigram Launches New Tube-style Pre-rolls: SHRED Dartz and Holy Smokes
Both SHRED Dartz and Holy Smokes come in 10x0.4g packs and are rolled with 100% organic hemp paper providing a more natural and elevated cannabis experience August 2nd, 2023
Toronto, Ontario – August 2, 2023 - Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the launch of its new tube-style pre-rolls, SHRED Dartz and Holy Smokes. These tube-style pre-rolls mark the inception of 0.4g pre-rolls for Organigram, crafted using the state-of-the-art, high-speed Cantos tube-style rolling machine, complemented by cutting-edge packaging capabilities. Organigram today, is one of a small number of licensed producers (LPs) in Canada that possess the equipment and expertise to manufacture this sophisticated tube-style pre-roll format.
Over the past year, tube-style pre-rolls have experienced a remarkable surge in Ontario, witnessing a 113% increase in the number of SKUs since last year (Q3 FY22 to Q3 FY23) [1]. Additionally, the sales of tube-style pre-rolls are nearly four times higher per SKU when compared to joints and 3 out of the top 5 bestselling SKUs are tube-style[2]. Due to their convenience, they are incredibly sought after and currently account for 14% of the total pre-roll category, and their growth trajectory is expected to continue[3]. Capitalizing on this opportunity, Organigram has launched these two new products and believes it has positioned itself to capture a significant share of this expanding category. As a result, Organigram also anticipates fostering the growth of the tube-style pre-roll sub-category over the next few months.
Each box of SHRED Dartz contains ten 0.4g tube-style pre-rolls and will be available in Tropic Thunder, Gnarberry and Funk Master, SHRED’s three best-selling blends. Reflecting the SHRED portfolio’s commitment to value, convenience, and bold flavour, SHRED Dartz will deliver on ‘SHRED Heads’ love of flavourful, colourful and convenient cannabis products with custom-coloured outer pouch, inner box and a branded filter for each unique blend.
Holy Smokes offers legendary, strain-specific pre-rolls with an imaginative and regal design that speaks to its unique and creative consumer. Each box contains ten 0.4g tube-style pre-rolls with three different single-strain SKUs including MAC-1, I.C.C. and GMO Tropical Reign. Holy Smokes features a reflective gold logo and halo design on the branded filter in addition to a custom-coloured outer pouch and inner box.
“As we launch both SHRED Dartz and Holy Smokes, we are catering to our core consumers' desires for exceptional pre-rolls that strike the perfect balance of quality and value. We understand the significance of meeting their expectations and going beyond, ensuring that every interaction with our products leaves a lasting impression. We crafted these tube style pre-rolls in response to their wants, tailored to fulfill the preferences customers truly care about. We are optimistic as we introduce both these products, offering customers a fantastic cannabis experience that is perfectly timed for the summer. With these exciting new offerings, we aim to elevate their enjoyment and create unforgettable moments,” says Megan McCrae, SVP, Marketing and Communications at Organigram.
Both SHRED Dartz and Holy Smokes are rolled with 100% organic hemp paper, offering customers a more natural and elevated experience compared to the standard white rolling paper. Holy Smokes is already available in the market for purchase and SHRED Dartz is currently available in all provinces except BC and PEI where they are expected to be available early August.
Learn more by following along on our Twitter pages @SHREDWEED @HolyMtnCannabis or visit our websites at www.shredcann.com & www.holymountaincannabis.ca
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiaries include: Organigram Inc. and Laurentian Organic Inc., licensed producers of cannabis and cannabis-derived products in Canada, and The Edibles and Infusions Corporation, a licensed manufacturer of cannabis-infused edibles in Canada.
Organigram is focused on producing high-quality, cannabis for patients and adult recreational consumers, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour, Laurentian, Tremblant Cannabis and Trailblazer. Organigram operates facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).
Forward-Looking Information
This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include changes to market conditions, consumer preferences and regulatory climate, and factors and risks as disclosed in the Company’s most recent annual information form, management’s discussion and analysis and other Company documents filed from time to time on SEDAR (see www.sedar.com) and filed or furnished to the Securities and Exchange Commission on EDGAR (see www.sec.gov). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
For Investor Relations enquiries:
Max Schwartz
Director of Investor Relations
investors@organigram.ca
Organigram
For Media enquiries:
Megan McCrae
Senior Vice President – Marketing and Communications
megan.mccrae@organigram.ca
SOURCE:Organigram https://investors.organigram.ca/press-releases/organigram-launches-new-tube-style-pre-rolls-shred-dartz-and-holy-smokes
.
Last 2 days $OGI has done quite decent for upward movement
$OGI having a decent day so far, up 6%
OGI No worries Tipsy, thanks!
HBG, didn't really mean to insult, more in the frame of "you do you".
On the bright side, it was way better than an unwanted lecture on the evils of dead money.
Have as good life.
Followers
|
180
|
Posters
|
|
Posts (Today)
|
1
|
Posts (Total)
|
11305
|
Created
|
08/27/14
|
Type
|
Free
|
Moderators WALL STREET KID Hunchbackgeek |
Efficient Vertical Growth Infrastructure! | 137 000 sq ft. Expansion Under Construction! | Recreational Edibles Coming! |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |